Viking Therapeutics, Inc. (NASDAQ:VKTX) Forecasted to Post Q1 2024 Earnings of ($0.25) Per Share
Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Equities researchers at HC Wainwright issued their Q1 2024 EPS estimates for shares of Viking Therapeutics in a research report issued on Thursday, February 8th. HC Wainwright analyst J. Pantginis anticipates that the biotechnology company will post earnings per share of ($0.25) for the quarter. The consensus […]
More Stories
StockNews.com Initiates Coverage on DURECT (NASDAQ:DRRX)
Equities research analysts at StockNews.com began coverage on shares of DURECT (NASDAQ:DRRX – Get Free Report) in a note issued...
StockNews.com Begins Coverage on Trio-Tech International (NYSE:TRT)
Analysts at StockNews.com began coverage on shares of Trio-Tech International (NYSE:TRT – Get Free Report) in a report released on...
Kate Dehoff Sells 6,205 Shares of Joby Aviation, Inc. (NYSE:JOBY) Stock
Joby Aviation, Inc. (NYSE:JOBY – Get Free Report) insider Kate Dehoff sold 6,205 shares of the stock in a transaction...
Truist Financial Has Lowered Expectations for International Game Technology (NYSE:IGT) Stock Price
International Game Technology (NYSE:IGT – Get Free Report) had its target price lowered by Truist Financial from $23.00 to $20.00...
Rostislav Christov Raykov Buys 19,200 Shares of Lavras Gold Corp. (CVE:LGC) Stock
Lavras Gold Corp. (CVE:LGC – Get Free Report) Director Rostislav Christov Raykov bought 19,200 shares of the firm’s stock in...
Morgan Stanley Has Lowered Expectations for Illumina (NASDAQ:ILMN) Stock Price
Illumina (NASDAQ:ILMN – Free Report) had its price objective decreased by Morgan Stanley from $156.00 to $150.00 in a research...